The DOI matches its Crossref record.
M5 muscarinic receptors are needed for slow activation of dopamine neurons and for rewarding brain stimulation
Abstract
Mesopontine cholinergic neurons (Ch5 and Ch6 cell groups) activate the cerebral cortex via thalamic projections, and activate locomotion and reward via dopamine neurons in the substantia nigra and ventral tegmental area (VTA). Nicotinic receptors in VTA activate dopamine neurons quickly, and are needed for the stimulant and rewarding effects of nicotine in rats. Muscarinic receptors in VTA activate dopamine neurons slowly, and are needed for the rewarding effects of hypothalamic stimulation, but do not increase locomotion. Antisense oligonucleotides targetting M5 mRNA, when infused into the VTA, inhibited M5 receptor binding and rewarding hypothalamic stimulation. Mutant mice with truncated M5 muscarinic receptor genes drank more water than wild-type controls. Spontaneous locomotion and locomotor responses to amphetamine and scopolamine were unchanged. Electrical stimulation near Ch6 induced dopamine release in the nucleus accumbens in two phases, an early phase (0-2 min after stimulation) dependent on nicotinic and gluatamatergic receptors in VTA, and a late phase (8-50 min after stimulation) dependent on muscarinic receptors in VTA. The late phase was lost in M5 mutant mice, while the early phase was unchanged. M5 muscarinic receptors bind slowly to muscarinic ligands, and appear to mediate slow secretions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Both muscarinic and nicotinic ACh receptors are present on VTA dopamine neurons, as well as on cholinergic and glutamatergic terminals regulating different aspects of dopamine release in output sites, such as the striatum and NAc [160–162].”
From Adolescent nicotine exposure and persistent neurocircuitry changes: unveiling lifelong psychiatric risks (2025) · cites this paper as [162]
Citations
Cited by
Sorted by citations
Wise, R. A. (2002) · Neuron · doi:10.1016/s0896-6273(02)00965-0 · Cited by 881
“…expressed by the dopaminergic neurons of this the D2-type receptors are largely restricted to a subpopulation of medium spiny neurons expressing enkephalinregion (Yeomans et al., 2000, 2001; Forster et al., 2002) Mesolimbic Afferents and projecting primarily to the pallidum (Gerfen, 1992).”
BackgroundDeYoung, C. G., Peterson, J. B., & Higgins, D. M. (2005) · Journal of Personality · doi:10.1111/j.1467-6494.2005.00330.x · Cited by 557
Muscarinic Acetylcholine Receptor Knockout Mice: Novel Phenotypes and Clinical Implications
Wess, J. (2004) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121622 · Cited by 381
Yamada, M., Lamping, K. G., Duttaroy, A., Zhang, W., Cui, Y., Bymaster, F. P., McKinzie, D. L., Felder, C. C., Deng, C., Faraci, F. M., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251542998 · Cited by 275
The Dopamine Hypothesis of Drug Addiction: Hypodopaminergic State
Melis, M., Spiga, S., & Diana, M. (2005) · International review of neurobiology · doi:10.1016/s0074-7742(05)63005-x · Cited by 282
“The initial fast response seems to be mediated by nicotinic receptors, whereas muscarinic receptors are responsible for a prolonged response (Yeomans et al., 2001).”
Background
Metadata
- Authors
- Yeomans, J., Forster, G., & Blaha, C.
- Affiliations
- University of Toronto (CA)
- Macquarie University (AU)
- Corresponding author
- Yeomans, John
- Venue
- Life Sciences
- Publisher
- Elsevier BV
- Published
- 2001-04
- Volume
- 68
- Issue
- 22-23
- Pages
- 2449-2456
- ISSN
- 0024-3205 (ISSN-L)
- OpenAlex
- W1999928356
- Cited by
- 124
- References
- 0
- Citations by year
- 2025: 2 · 2023: 3 · 2022: 2 · 2021: 2 · 2020: 2 · 2019: 6 · 2018: 2 · 2017: 3 · 2016: 4 · 2015: 1 · 2014: 4 · 2013: 3 · 2012: 2
- FWCI
- 3.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Life Sciences (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Keywords
- M5 muscarinic receptor, dopaminergic neurons, ventral tegmental area, nicotinic acetylcholine receptors, reward, brain stimulation, substantia nigra, nucleus accumbens dopamine release, antisense oligonucleotides, locomotion
- MeSH terms
- Acetylcholine, Animals, Corpus Striatum, Dopamine, Electric Stimulation, Humans, Hypothalamus, Neurons, Receptors, Muscarinic, Receptors, Nicotinic, Reward, Receptor, Muscarinic M5
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
